Nervosave Therapeutics
NVO-701 / Hearing & ageing

Exploring auditory nerve health

An early-stage program investigating local therapeutic approaches to auditory nerve dysfunction and age-associated hearing challenges.

Hearing health visual
Program overview

The challenge

Auditory nerve dysfunction can contribute to difficulties with hearing and sound processing. Ageing, injury and other factors may affect neural components of hearing.

Research direction

NVO-701 explores whether Nervosave’s nerve-targeted delivery expertise could be adapted to selected auditory nerve applications. This is a research direction, not an established treatment.

Development status

The program is exploratory and preclinical. Clinical safety, efficacy and feasibility for hearing indications remain to be demonstrated.

At a glance

Program focus

  • Auditory nerve focus
  • Age-related nerve health
  • Early-stage research
  • No proven clinical benefit

Investigational research program. Preclinical observations do not demonstrate clinical safety or efficacy.

Collaborate with Nervosave

Advance nerve health innovation

We welcome conversations with scientific, clinical and strategic partners.